• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fine-Tuning Cytokine Signals.细胞因子信号的微调。
Annu Rev Immunol. 2019 Apr 26;37:295-324. doi: 10.1146/annurev-immunol-042718-041447. Epub 2019 Jan 16.
2
Making sense of IL-6 signalling cues in pathophysiology.解析病理生理学中的 IL-6 信号线索。
FEBS Lett. 2022 Mar;596(5):567-588. doi: 10.1002/1873-3468.14201. Epub 2021 Oct 15.
3
Interpreting mixed signals: the cell's cytokine conundrum.解读复杂信号:细胞细胞因子的难题。
Curr Opin Immunol. 2011 Oct;23(5):632-8. doi: 10.1016/j.coi.2011.07.013. Epub 2011 Aug 16.
4
Molecular and cellular factors determining the functional pleiotropy of cytokines.决定细胞因子功能多效性的分子和细胞因素。
FEBS J. 2023 May;290(10):2525-2552. doi: 10.1111/febs.16420. Epub 2022 Mar 14.
5
Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.JAK/STAT信号通路在T细胞淋巴瘤发病机制中的紊乱:对免疫治疗的意义。
Annu Rev Immunol. 2017 Apr 26;35:533-550. doi: 10.1146/annurev-immunol-110416-120628. Epub 2017 Feb 9.
6
Mapping Determinants of Cytokine Signaling via Protein Engineering.通过蛋白质工程绘制细胞因子信号转导的决定因素。
Front Immunol. 2018 Sep 27;9:2143. doi: 10.3389/fimmu.2018.02143. eCollection 2018.
7
The molecular details of cytokine signaling via the JAK/STAT pathway.JAK/STAT 通路介导的细胞因子信号转导的分子细节。
Protein Sci. 2018 Dec;27(12):1984-2009. doi: 10.1002/pro.3519.
8
The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.促红细胞生成素和促炎细胞因子介导的JAK/STAT信号通路在脑瘫患儿中的作用
Brain Dev. 2009 Mar;31(3):200-7. doi: 10.1016/j.braindev.2008.06.011. Epub 2008 Aug 19.
9
Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.糖蛋白 130 细胞因子信号作为心血管疾病的治疗靶点。
J Pharmacol Sci. 2011;117(4):213-22. doi: 10.1254/jphs.11r05cr. Epub 2011 Nov 5.
10
Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.胰岛素样生长因子-I受体信号转导与Janus激酶/信号转导子和转录激活子(JAK-STAT)通路。
Biofactors. 2009 Jan-Feb;35(1):76-81. doi: 10.1002/biof.20.

引用本文的文献

1
Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directions.免疫治疗中的表型和靶向药物发现:挑战、机遇与未来方向。
RSC Adv. 2025 Aug 22;15(36):29937-29951. doi: 10.1039/d5ra03914b. eCollection 2025 Aug 18.
2
Surface-Engineered Natural Killer Cell-Derived Small Extracellular Vesicles Induce Potent Anti-Tumour Effects in Lung Cancer Cells.表面工程化的自然杀伤细胞衍生的小细胞外囊泡对肺癌细胞具有强大的抗肿瘤作用。
J Extracell Biol. 2025 Aug 20;4(8):e70080. doi: 10.1002/jex2.70080. eCollection 2025 Aug.
3
Pattern recognition in living cells through the lens of machine learning.通过机器学习视角实现活细胞中的模式识别。
Open Biol. 2025 Jul;15(7):240377. doi: 10.1098/rsob.240377. Epub 2025 Jul 16.
4
Proteomic characteristics of bronchoalveolar lavage fluid in children with mild and severe pneumonia.轻度和重度肺炎患儿支气管肺泡灌洗液的蛋白质组学特征
Front Microbiol. 2025 May 19;16:1595521. doi: 10.3389/fmicb.2025.1595521. eCollection 2025.
5
Enhanced IL36RN Expression and Its Association With Immune Microenvironment Predicts Poor Prognosis in Gastric Cancer.IL36RN表达增强及其与免疫微环境的关联预示胃癌预后不良。
Cancer Med. 2025 May;14(9):e70954. doi: 10.1002/cam4.70954.
6
STAT Signature Dish: Serving Immunity with a Side of Dietary Control.STAT特色菜品:提供免疫力并辅以饮食控制。
Biomolecules. 2025 Mar 26;15(4):487. doi: 10.3390/biom15040487.
7
Novel first-trimester serum biomarkers for early prediction of gestational diabetes mellitus.用于早期预测妊娠期糖尿病的新型孕早期血清生物标志物。
Nutr Diabetes. 2025 Apr 12;15(1):15. doi: 10.1038/s41387-025-00372-z.
8
Brain-wide mapping of immune receptors uncovers a neuromodulatory role of IL-17E and the receptor IL-17RB.全脑免疫受体图谱揭示了白细胞介素-17E和受体白细胞介素-17RB的神经调节作用。
Cell. 2025 Apr 17;188(8):2203-2217.e17. doi: 10.1016/j.cell.2025.03.006. Epub 2025 Apr 7.
9
Viral sepsis - pathophysiology and disease manifestation.病毒性脓毒症——病理生理学与疾病表现
Infection. 2025 Feb 17. doi: 10.1007/s15010-025-02486-z.
10
Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.模拟对白介素-21的反应以指导自然杀伤细胞免疫疗法。
Immunol Cell Biol. 2025 Feb;103(2):192-212. doi: 10.1111/imcb.12848. Epub 2025 Jan 25.

本文引用的文献

1
Emerging Therapies for Inflammatory Bowel Disease.炎症性肠病的新兴治疗方法。
Adv Ther. 2018 Nov;35(11):1746-1762. doi: 10.1007/s12325-018-0795-9. Epub 2018 Oct 29.
2
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism.一种基于结构的机制增强调节性 T 细胞功能的人源抗 IL-2 抗体。
Nat Med. 2018 Jul;24(7):1005-1014. doi: 10.1038/s41591-018-0070-2. Epub 2018 Jun 25.
3
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.肠上皮细胞中的自噬在肿瘤发生过程中触发适应性免疫。
Cell. 2018 Jun 28;174(1):88-101.e16. doi: 10.1016/j.cell.2018.05.028. Epub 2018 Jun 14.
4
An Update on JAK Inhibitors.JAK 抑制剂的最新进展
Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502.
5
CAR T cell immunotherapy for human cancer.嵌合抗原受体 T 细胞免疫疗法治疗人类癌症。
Science. 2018 Mar 23;359(6382):1361-1365. doi: 10.1126/science.aar6711.
6
Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1.Fas 通过结合和隔离转录因子 STAT1 促进辅助性 T 细胞 17 分化并抑制辅助性 T 细胞 1 发育。
Immunity. 2018 Mar 20;48(3):556-569.e7. doi: 10.1016/j.immuni.2018.03.008.
7
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.使用正交的 IL-2 细胞因子受体复合物对工程 T 细胞进行选择性靶向。
Science. 2018 Mar 2;359(6379):1037-1042. doi: 10.1126/science.aar3246.
8
Mutations in the signal transducer and activator of transcription family of genes in cancer.癌症中转录信号转导子与激活子家族基因的突变
Cancer Sci. 2018 Apr;109(4):926-933. doi: 10.1111/cas.13525. Epub 2018 Mar 2.
9
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.针对癌症中的 IL-6/JAK/STAT3 信号通路。
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248. doi: 10.1038/nrclinonc.2018.8. Epub 2018 Feb 6.
10
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.一种新型嵌合抗原受体,包含 JAK-STAT 信号域,介导优越的抗肿瘤效应。
Nat Med. 2018 Mar;24(3):352-359. doi: 10.1038/nm.4478. Epub 2018 Feb 5.

细胞因子信号的微调。

Fine-Tuning Cytokine Signals.

机构信息

Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-1674, USA; email:

出版信息

Annu Rev Immunol. 2019 Apr 26;37:295-324. doi: 10.1146/annurev-immunol-042718-041447. Epub 2019 Jan 16.

DOI:10.1146/annurev-immunol-042718-041447
PMID:30649989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10822674/
Abstract

Cytokines are secreted or otherwise released polypeptide factors that exert autocrine and/or paracrine actions, with most cytokines acting in the immune and/or hematopoietic system. They are typically pleiotropic, controlling development, cell growth, survival, and/or differentiation. Correspondingly, cytokines are clinically important, and augmenting or attenuating cytokine signals can have deleterious or therapeutic effects. Besides physiological fine-tuning of cytokine signals, altering the nature or potency of the signal can be important in pathophysiological responses and can also provide novel therapeutic approaches. Here, we give an overview of cytokines, their signaling and actions, and the physiological mechanisms and pharmacologic strategies to fine-tune their actions. In particular, the differential utilization of STAT proteins by a single cytokine or by different cytokines and STAT dimerization versus tetramerization are physiological mechanisms of fine-tuning, whereas anticytokine and anticytokine receptor antibodies and cytokines with altered activities, including cytokine superagonists, partial agonists, and antagonists, represent new ways of fine-tuning cytokine signals.

摘要

细胞因子是分泌或其他方式释放的多肽因子,发挥自分泌和/或旁分泌作用,大多数细胞因子在免疫和/或造血系统中发挥作用。它们通常具有多效性,控制着发育、细胞生长、存活和/或分化。相应地,细胞因子具有重要的临床意义,增强或减弱细胞因子信号可能产生有害或治疗效果。除了细胞因子信号的生理微调外,改变信号的性质或效力在病理生理反应中也很重要,并且还可以提供新的治疗方法。在这里,我们概述了细胞因子及其信号转导和作用,以及生理机制和药理学策略来微调它们的作用。特别是,单个细胞因子或不同细胞因子对 STAT 蛋白的不同利用以及 STAT 二聚体与四聚体化是微调的生理机制,而抗细胞因子和抗细胞因子受体抗体以及具有改变活性的细胞因子,包括细胞因子超激动剂、部分激动剂和拮抗剂,则代表了微调细胞因子信号的新方法。